Abstract
Summary We demonstrate the feasibility of 3D myocardial perfusion CMR at 3 Tesla against fractional flow reserve (FFR) in 53 patients for the detection of flow-limiting coronary artery disease and show good agreement between the techniques. This technique shows excellent diagnostic sensitivity and specificity and may offer an alternative method of detecting ischaemia for the purpose of guiding revascularisation and risk stratification. Background Three-dimensional (3D) myocardial perfusion cardiovascular magnetic resonance (CMR) has recently been proposed to overcome the limited spatial coverage of conventional perfusion CMR methods1. The method has shown good diagnostic accuracy for the detection of coronary artery disease determined by quantitative coronary angiography (QCA)2. However the relationship between the severity of a coronary stenosis on QCA and its functional significance is variable. Pressure wirederived fractional flow reserve (FFR) <0.75 correlates closely with objective evidence of reversible ischemia and it has been demonstrated that ischaemia-guided PCI confers a prognostic benefit. Aim To determine the diagnostic accuracy of whole heart 3D myocardial perfusion CMR against invasively determined FFR.
Highlights
Three-dimensional (3D) myocardial perfusion cardiovascular magnetic resonance (CMR) has recently been proposed to overcome the limited spatial coverage of conventional perfusion CMR methods[1]
The method has shown good diagnostic accuracy for the detection of coronary artery disease determined by quantitative coronary angiography (QCA)[2]
Aim To determine the diagnostic accuracy of whole heart 3D myocardial perfusion CMR against invasively determined fractional flow reserve (FFR)
Summary
Roy Jogiya1*, Geraint Morton[1], Kalpa De Silva[1], Simon Redwood[1], Sebastian Kozerke[3], Divaka Perera[1], Eike Nagel[1], Sven Plein[2]. This technique shows excellent diagnostic sensitivity and specificity and may offer an alternative method of detecting ischaemia for the purpose of guiding revascularisation and risk stratification
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
